The preRC protein ORCA organizes heterochromatin by assembling histone H3 lysine 9 methyltransferases on chromatin

  1. Sumanprava Giri
  2. Vasudha Aggarwal
  3. Julien Pontis
  4. Zhen Shen
  5. Arindam Chakraborty
  6. Abid Khan
  7. Craig Mizzen
  8. Kannanganattu V Prasanth
  9. Slimane Ait-Si-Ali
  10. Taekjip Ha
  11. Supriya G Prasanth  Is a corresponding author
  1. University of Illinois at Urbana-Champaign, United States
  2. Centre National de la Recherche Scientifique, France

Abstract

Heterochromatic domains are enriched with repressive histone marks, including histone H3 lysine 9 methylation, written by lysine methyltransferases (KMTs). The pre-replication complex protein Origin Recognition Complex-Associated (ORCA/LRWD1) preferentially localizes to heterochromatic regions in post-replicated cells. Its role in heterochromatin organization remained elusive. ORCA recognizes methylated H3K9 marks and interacts with repressive KMTs, including G9a/GLP and Suv39H1 in a chromatin context-dependent manner. Single-molecule pull-down assays demonstrate that ORCA-ORC and multiple H3K9 KMTs exist in a single complex and that ORCA stabilizes H3K9 KMT complex. Cells lacking ORCA show alterations in chromatin architecture, with significantly reduced H3K9 di- and tri-methylation at specific chromatin sites. Changes in heterochromatin structure due to loss of ORCA affects replication timing, preferentially at the late-replicating regions. We demonstrate that ORCA acts as a scaffold for the establishment of H3K9 KMT complex and its association and activity at specific chromatin sites is crucial for the organization of heterochromatin structure.

Article and author information

Author details

  1. Sumanprava Giri

    Department of Cell and Developmental Biology,, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  2. Vasudha Aggarwal

    Center for Biophysics and Computational Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  3. Julien Pontis

    Université Paris Diderot, Sorbonne Paris Cité, Laboratoire Epigénétique et Destin Cellulaire, UMR7216, Centre National de la Recherche Scientifique, Paris, France
    Competing interests
    No competing interests declared.
  4. Zhen Shen

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  5. Arindam Chakraborty

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  6. Abid Khan

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  7. Craig Mizzen

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  8. Kannanganattu V Prasanth

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    No competing interests declared.
  9. Slimane Ait-Si-Ali

    Université Paris Diderot, Sorbonne Paris Cité, Laboratoire Epigénétique et Destin Cellulaire, UMR7216, Centre National de la Recherche Scientifique, Paris, France
    Competing interests
    No competing interests declared.
  10. Taekjip Ha

    Center for Biophysics and Computational Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    Competing interests
    Taekjip Ha, Reviewing editor, eLife.
  11. Supriya G Prasanth

    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Champaign, United States
    For correspondence
    supriyap@life.illinois.edu
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. Michael R Botchan, University of California, Berkeley, United States

Version history

  1. Received: January 15, 2015
  2. Accepted: April 27, 2015
  3. Accepted Manuscript published: April 29, 2015 (version 1)
  4. Version of Record published: May 26, 2015 (version 2)

Copyright

© 2015, Giri et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,084
    views
  • 771
    downloads
  • 35
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sumanprava Giri
  2. Vasudha Aggarwal
  3. Julien Pontis
  4. Zhen Shen
  5. Arindam Chakraborty
  6. Abid Khan
  7. Craig Mizzen
  8. Kannanganattu V Prasanth
  9. Slimane Ait-Si-Ali
  10. Taekjip Ha
  11. Supriya G Prasanth
(2015)
The preRC protein ORCA organizes heterochromatin by assembling histone H3 lysine 9 methyltransferases on chromatin
eLife 4:e06496.
https://doi.org/10.7554/eLife.06496

Share this article

https://doi.org/10.7554/eLife.06496

Further reading

    1. Cancer Biology
    2. Cell Biology
    Camille Dantzer, Justine Vaché ... Violaine Moreau
    Research Article

    Immune checkpoint inhibitors have produced encouraging results in cancer patients. However, the majority of ß-catenin-mutated tumors have been described as lacking immune infiltrates and resistant to immunotherapy. The mechanisms by which oncogenic ß-catenin affects immune surveillance remain unclear. Herein, we highlighted the involvement of ß-catenin in the regulation of the exosomal pathway and, by extension, in immune/cancer cell communication in hepatocellular carcinoma (HCC). We showed that mutated ß-catenin represses expression of SDC4 and RAB27A, two main actors in exosome biogenesis, in both liver cancer cell lines and HCC patient samples. Using nanoparticle tracking analysis and live-cell imaging, we further demonstrated that activated ß-catenin represses exosome release. Then, we demonstrated in 3D spheroid models that activation of β-catenin promotes a decrease in immune cell infiltration through a defect in exosome secretion. Taken together, our results provide the first evidence that oncogenic ß-catenin plays a key role in exosome biogenesis. Our study gives new insight into the impact of ß-catenin mutations on tumor microenvironment remodeling, which could lead to the development of new strategies to enhance immunotherapeutic response.

    1. Cell Biology
    Zhongyun Xie, Yongping Chai ... Wei Li
    Research Article

    Asymmetric cell divisions (ACDs) generate two daughter cells with identical genetic information but distinct cell fates through epigenetic mechanisms. However, the process of partitioning different epigenetic information into daughter cells remains unclear. Here, we demonstrate that the nucleosome remodeling and deacetylase (NuRD) complex is asymmetrically segregated into the surviving daughter cell rather than the apoptotic one during ACDs in Caenorhabditis elegans. The absence of NuRD triggers apoptosis via the EGL-1-CED-9-CED-4-CED-3 pathway, while an ectopic gain of NuRD enables apoptotic daughter cells to survive. We identify the vacuolar H+–adenosine triphosphatase (V-ATPase) complex as a crucial regulator of NuRD’s asymmetric segregation. V-ATPase interacts with NuRD and is asymmetrically segregated into the surviving daughter cell. Inhibition of V-ATPase disrupts cytosolic pH asymmetry and NuRD asymmetry. We suggest that asymmetric segregation of V-ATPase may cause distinct acidification levels in the two daughter cells, enabling asymmetric epigenetic inheritance that specifies their respective life-versus-death fates.